IRIDEX Corp Sustainability Reports

IRIDEX Corporation develops, manufactures, and markets innovative, laser-based medical systems, delivery devices, and consumable instrumentation for the ophthalmology market. Its products are primarily used in the treatment of glaucoma and retinal diseases.

Sector: Manufacturing

Country: United States

Exchange: Nasdaq

FIGI: BBG001S7J0Y3

7 reports from 2009 to 2024

• IRIDEX Corp 2024 Annual Report Form 10-K
• IRIDEX Corp 2022 Form 10-K
• IRIDEX Corp 2021 Form 10-K
• IRIDEX Corp 2017 Annual Report to Stockholders
• IRIDEX Corp 2013 Form 10-K